These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15180262)

  • 1. Mouse models of human retinal disease caused by expression of mutant rhodopsin. A valuable tool for the assessment of novel gene therapies.
    Nour M; Naash MI
    Adv Exp Med Biol; 2003; 533():173-9. PubMed ID: 15180262
    [No Abstract]   [Full Text] [Related]  

  • 2. The eyes have it.
    Hauswirth WW; Timmers AM
    Mol Med Today; 2000 Feb; 6(2):51. PubMed ID: 10681166
    [No Abstract]   [Full Text] [Related]  

  • 3. The eye photoreceptor protein rhodopsin. Structural implications for retinal disease.
    Garriga P; Manyosa J
    FEBS Lett; 2002 Sep; 528(1-3):17-22. PubMed ID: 12297272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhodopsin gene codon 106 mutation (Gly-to-Arg) in a Japanese family with autosomal dominant retinitis pigmentosa.
    Budu ; Matsumoto M; Hayasaka S; Yamada T; Hayasaka Y
    Jpn J Ophthalmol; 2000; 44(6):610-4. PubMed ID: 11094174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of dominant mutations of rhodopsin and implications for gene therapy.
    Wilson JH; Wensel TG
    Mol Neurobiol; 2003 Oct; 28(2):149-58. PubMed ID: 14576453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
    Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
    Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mice with a D190N mutation in the gene encoding rhodopsin: a model for human autosomal-dominant retinitis pigmentosa.
    Sancho-Pelluz J; Tosi J; Hsu CW; Lee F; Wolpert K; Tabacaru MR; Greenberg JP; Tsang SH; Lin CS
    Mol Med; 2012 May; 18(1):549-55. PubMed ID: 22252712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different amino acid substitutions at the same position in rhodopsin lead to distinct phenotypes.
    Neidhardt J; Barthelmes D; Farahmand F; Fleischhauer JC; Berger W
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1630-5. PubMed ID: 16565402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal degeneration in humanized mice expressing mutant rhodopsin under the control of the endogenous murine promoter.
    Liu X; Jia R; Meng X; Li Y; Yang L
    Exp Eye Res; 2022 Feb; 215():108893. PubMed ID: 34919893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene delivery of wild-type rhodopsin rescues retinal function in an autosomal dominant retinitis pigmentosa mouse model.
    Mao H; Gorbatyuk MS; Hauswirth WW; Lewin AS
    Adv Exp Med Biol; 2012; 723():199-205. PubMed ID: 22183334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
    Rossmiller B; Mao H; Lewin AS
    Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
    Meng D; Ragi SD; Tsang SH
    Mol Ther; 2020 Oct; 28(10):2139-2149. PubMed ID: 32882181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
    Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
    Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa.
    Olsson JE; Gordon JW; Pawlyk BS; Roof D; Hayes A; Molday RS; Mukai S; Cowley GS; Berson EL; Dryja TP
    Neuron; 1992 Nov; 9(5):815-30. PubMed ID: 1418997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations within the rhodopsin gene in patients with autosomal dominant retinitis pigmentosa.
    Dryja TP; McGee TL; Hahn LB; Cowley GS; Olsson JE; Reichel E; Sandberg MA; Berson EL
    N Engl J Med; 1990 Nov; 323(19):1302-7. PubMed ID: 2215617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optogenetic Retinal Gene Therapy with the Light Gated GPCR Vertebrate Rhodopsin.
    Gaub BM; Berry MH; Visel M; Holt A; Isacoff EY; Flannery JG
    Methods Mol Biol; 2018; 1715():177-189. PubMed ID: 29188513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin.
    Macke JP; Davenport CM; Jacobson SG; Hennessey JC; Gonzalez-Fernandez F; Conway BP; Heckenlively J; Palmer R; Maumenee IH; Sieving P
    Am J Hum Genet; 1993 Jul; 53(1):80-9. PubMed ID: 8317502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural, energetic, and mechanical perturbations in rhodopsin mutant that causes congenital stationary night blindness.
    Kawamura S; Colozo AT; Ge L; Müller DJ; Park PS
    J Biol Chem; 2012 Jun; 287(26):21826-35. PubMed ID: 22549882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsin localization and rhodopsin photochemistry in a transgenic mouse model of retinitis pigmentosa.
    Wu TH; Ting TD; Okajima TI; Pepperberg DR; Ho YK; Ripps H; Naash MI
    Neuroscience; 1998 Dec; 87(3):709-17. PubMed ID: 9758235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhodopsin mutations in autosomal dominant retinitis pigmentosa.
    Sung CH; Davenport CM; Hennessey JC; Maumenee IH; Jacobson SG; Heckenlively JR; Nowakowski R; Fishman G; Gouras P; Nathans J
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6481-5. PubMed ID: 1862076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.